| 產(chǎn)品編號(hào) | BSKV0001 |
| 英文名稱 | SARS-CoV-2 (2019-nCoV) Nucleoprotein ELISA Kit |
| 中文名稱 | |
| 別 名 | SARS-CoV-2 Nucleocapsid Protein; SARS-CoV-2 NP; nucleocapsid protein [Severe acute respiratory syndrome coronavirus 2]; novel coronavirus N Protein; novel coronavirus Nucleocapsid Protein; 2019-nCoV Nucleoprotein; 2019-nCoV N; 2019nCoV N; 2019-nCoV N Protein; 2019 ncov N Protein; 2019-nCoV nucleocapsid protein; SARS-CoV-2 N ELISA Kit |
 |
Specific References (1) | BSKV0001 has been referenced in 1 publications.
[IF=4.101] Jeremy R.A. Paull. et al. Virucidal and antiviral activity of astodrimer sodium against SARS-CoV-2 in vitro. Antivir Res. 2021 Jul;191:105089 ELISA ; Human.
|
| 線性范圍 | 0.78 - 25ng/ml |
| 應(yīng)用范圍 | S/P/CC |
| 檢測(cè)限 | 0.4 ng/ml |
| 適用樣品基質(zhì) | cell culture supernates and cell culture exctracts |
| 保存條件 | Store at 4°C for 6 months, at -20°C for 12 months. Avoid multiple freeze-thaw cycles (Shipped with wet ice.). |
| 注意事項(xiàng) | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| 產(chǎn)品介紹 |
Coronaviruses are enveloped viruses with a positive-sense RNA genome and with a nucleocapsid of helical symmetry. Coronavirus nucleoproteins localize to the cytoplasm and the nucleolus, a subnuclear structure, in both virus-infected primary cells and in cells transfected with plasmids that express N protein. Coronavirus N protein is required for coronavirus RNA synthesis, and has RNA chaperone activity that may be involved in template switch. Nucleocapsid protein is a most abundant protein of coronavirus. During virion assembly, N protein binds to viral RNA and leads to formation of the helical nucleocapsid. Nucleocapsid protein is a highly immunogenic phosphoprotein also implicated in viral genome replication and in modulating cell signaling pathways. Because of the conservation of N protein sequence and its strong immunogenicity, the N protein of coronavirus is chosen as a diagnostic tool. ??為應(yīng)對(duì) COVID-19疫情的爆發(fā)，北京博奧森生物技術(shù)有限公司啟動(dòng)了針對(duì)新型冠狀病毒的科研攻關(guān)，成功研發(fā)出SARS-CoV-2 (2019-nCoV) Nucleoprotein蛋白檢測(cè)試劑盒。??該試劑盒根據(jù)ELISA雙抗體夾心法原理，采用一步法，實(shí)現(xiàn)對(duì)2019-nCoV抗原蛋白的快速準(zhǔn)確檢測(cè)。試劑盒所采用原料均來(lái)自本公司科研團(tuán)隊(duì)自主研發(fā)，經(jīng)嚴(yán)苛篩選驗(yàn)證，保證其靈敏度高、特異性好，結(jié)果一致且可靠，為疫情的相關(guān)疫苗及治療性藥物研究等工作貢獻(xiàn)一份力量。 產(chǎn)品特色： 1 時(shí)間短，提高檢測(cè)效率； 2 操作簡(jiǎn)便，實(shí)驗(yàn)誤差更小； 3 樣本需求量小，節(jié)約珍貴檢測(cè)樣本； 4 靈敏度高及特異性好，結(jié)果一致且可靠。 |
| 產(chǎn)品圖片 |
SARS-CoV-2 (2019-nCoV) Nucleoprotein ELISA Kit
Example of linearity and sensitivity of SARS-CoV-2 (2019-nCoV) Nucleoprotein ELISA Kit
|
